Newsbenzinga
Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible Takeover
· Published
Article summary
Private equity giants circle Qiagen (QGEN) with potential bids of $50/share. Get the details on the molecular diagnostics buyout.
An excerpt from the original article.
Comments —
Loading comments…